869 related articles for article (PubMed ID: 30622542)
21. HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells.
Chung NP; Matthews K; Klasse PJ; Sanders RW; Moore JP
J Immunol; 2012 Dec; 189(11):5257-65. PubMed ID: 23100517
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children.
Marr N; Wang TI; Kam SH; Hu YS; Sharma AA; Lam A; Markowski J; Solimano A; Lavoie PM; Turvey SE
J Immunol; 2014 Feb; 192(3):948-57. PubMed ID: 24391215
[TBL] [Abstract][Full Text] [Related]
23. Human plasmacytoid dendritic cells acquire phagocytic capacity by TLR9 ligation in the presence of soluble factors produced by renal epithelial cells.
Ruben JM; García-Romo GS; Breman E; van der Kooij S; Redeker A; Arens R; van Kooten C
Kidney Int; 2018 Feb; 93(2):355-364. PubMed ID: 29061332
[TBL] [Abstract][Full Text] [Related]
24. Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1.
Rahman MJ; Rahir G; Dong MB; Zhao Y; Rodrigues KB; Hotta-Iwamura C; Chen Y; Guerrero A; Tarbell KV
J Immunol; 2016 Mar; 196(5):2031-40. PubMed ID: 26826238
[TBL] [Abstract][Full Text] [Related]
25. Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
Nierkens S; den Brok MH; Garcia Z; Togher S; Wagenaars J; Wassink M; Boon L; Ruers TJ; Figdor CG; Schoenberger SP; Adema GJ; Janssen EM
Cancer Res; 2011 Oct; 71(20):6428-37. PubMed ID: 21788345
[TBL] [Abstract][Full Text] [Related]
26. Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response.
Basit F; Mathan T; Sancho D; de Vries IJM
Front Immunol; 2018; 9():2489. PubMed ID: 30455688
[TBL] [Abstract][Full Text] [Related]
27. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
Front Immunol; 2018; 9():364. PubMed ID: 29535732
[TBL] [Abstract][Full Text] [Related]
28. Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons.
Bruni D; Chazal M; Sinigaglia L; Chauveau L; Schwartz O; Desprès P; Jouvenet N
Sci Signal; 2015 Mar; 8(366):ra25. PubMed ID: 25737587
[TBL] [Abstract][Full Text] [Related]
29. Role of Toll-like receptors and retinoic acid inducible gene I in endogenous production of type I interferon in dermatomyositis.
Li L; Dai T; Lv J; Ji K; Liu J; Zhang B; Yan C
J Neuroimmunol; 2015 Aug; 285():161-8. PubMed ID: 26198935
[TBL] [Abstract][Full Text] [Related]
30. Sca-1 expression defines developmental stages of mouse pDCs that show functional heterogeneity in the endosomal but not lysosomal TLR9 response.
Niederquell M; Kurig S; Fischer JA; Tomiuk S; Swiecki M; Colonna M; Johnston IC; Dzionek A
Eur J Immunol; 2013 Nov; 43(11):2993-3005. PubMed ID: 23922217
[TBL] [Abstract][Full Text] [Related]
31. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
32. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.
Saitoh T; Satoh T; Yamamoto N; Uematsu S; Takeuchi O; Kawai T; Akira S
Immunity; 2011 Mar; 34(3):352-63. PubMed ID: 21435586
[TBL] [Abstract][Full Text] [Related]
33. Interferon-α and interleukin-12 are induced, respectively, by double-stranded DNA and single-stranded RNA in human myeloid dendritic cells.
Katashiba Y; Miyamoto R; Hyo A; Shimamoto K; Murakami N; Ogata M; Amakawa R; Inaba M; Nomura S; Fukuhara S; Ito T
Immunology; 2011 Feb; 132(2):165-73. PubMed ID: 20875078
[TBL] [Abstract][Full Text] [Related]
34. Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN.
Shimizu K; Yamasaki S; Sakurai M; Yumoto N; Ikeda M; Mishima-Tsumagari C; Kukimoto-Niino M; Watanabe T; Kawamura M; Shirouzu M; Fujii SI
Front Immunol; 2019; 10():1450. PubMed ID: 31293597
[TBL] [Abstract][Full Text] [Related]
35. TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells.
Fiola S; Gosselin D; Takada K; Gosselin J
J Immunol; 2010 Sep; 185(6):3620-31. PubMed ID: 20713890
[TBL] [Abstract][Full Text] [Related]
36. Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia.
Murugina NE; Budikhina AS; Dagil YA; Maximchik PV; Balyasova LS; Murugin VV; Melnikov MV; Sharova VS; Nikolaeva AM; Chkadua GZ; Pinegin BV; Pashenkov MV
J Biol Chem; 2020 Mar; 295(10):3099-3114. PubMed ID: 32005665
[TBL] [Abstract][Full Text] [Related]
37. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
38. Toll-like Receptor 4-Induced Glycolytic Burst in Human Monocyte-Derived Dendritic Cells Results from p38-Dependent Stabilization of HIF-1α and Increased Hexokinase II Expression.
Perrin-Cocon L; Aublin-Gex A; Diaz O; Ramière C; Peri F; André P; Lotteau V
J Immunol; 2018 Sep; 201(5):1510-1521. PubMed ID: 30037846
[TBL] [Abstract][Full Text] [Related]
39. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
[TBL] [Abstract][Full Text] [Related]
40. Self-priming determines high type I IFN production by plasmacytoid dendritic cells.
Kim S; Kaiser V; Beier E; Bechheim M; Guenthner-Biller M; Ablasser A; Berger M; Endres S; Hartmann G; Hornung V
Eur J Immunol; 2014 Mar; 44(3):807-818. PubMed ID: 24338737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
